- Long-term use of inhaled corticosteroids in COPD linked to higher risks of type 2 diabetes, pneumonia, cataracts, osteoporosis, and fractures.
- The study analyzed data from over 500,000 COPD patients, highlighting the significant findings.
- Current clinical guidelines recommend cautious use of inhaled corticosteroids, primarily in patients with frequent exacerbations and high eosinophil counts.
- The number needed to harm for developing health outcomes associated with long-term ICS in COPD patients is 5.
- Inhaled corticosteroids may benefit some patients, but unnecessary risks should be mitigated.
- The study emphasizes the need for reevaluation and cautious use of inhaled corticosteroids in COPD management to ensure patient safety.
Source: Annals of Family Medicine
